4-[5-(4-Fluoro-phenyl)-2-(1-methyl-piperidin-4-yl)-1H-imidazol-4-yl]-pyridine

ID: ALA365076

PubChem CID: 11500956

Max Phase: Preclinical

Molecular Formula: C20H21FN4

Molecular Weight: 336.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1

Standard InChI:  InChI=1S/C20H21FN4/c1-25-12-8-16(9-13-25)20-23-18(14-2-4-17(21)5-3-14)19(24-20)15-6-10-22-11-7-15/h2-7,10-11,16H,8-9,12-13H2,1H3,(H,23,24)

Standard InChI Key:  XIRXPGXOBQGWNW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    2.9292   -2.1875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -2.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0042   -3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7542   -3.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -2.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2917   -3.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -3.3250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1375   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5417   -1.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -0.5542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5750   -3.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3042   -4.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4167   -3.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6625   -2.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2292   -3.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250   -4.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1333   -3.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917   -4.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8375   -4.8542    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.5667   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2042   -0.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1875   -1.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7750   -0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500   -1.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  5  2  0
  5  1  1  0
  6  3  1  0
  7 15  1  0
  8  5  1  0
  9  2  1  0
 10 23  2  0
 11  6  2  0
 12  6  1  0
 13  8  1  0
 14  8  1  0
 15 14  1  0
 16 13  1  0
 17 19  1  0
 18 11  1  0
 19 12  2  0
 20 17  1  0
 21  7  1  0
 22 24  2  0
 23 25  1  0
 24  9  1  0
 25  9  2  0
  3  4  1  0
 16  7  1  0
 22 10  1  0
 18 17  2  0
M  END

Associated Targets(non-human)

Eimeria acervulina (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PKG cGMP-dependent protein kinase (275 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eimeria tenella (990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 336.41Molecular Weight (Monoisotopic): 336.1750AlogP: 4.09#Rotatable Bonds: 3
Polar Surface Area: 44.81Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.83CX Basic pKa: 9.03CX LogP: 2.99CX LogD: 1.35
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -1.20

References

1. Biftu T, Feng D, Ponpipom M, Girotra N, Liang GB, Qian X, Bugianesi R, Simeone J, Chang L, Gurnett A, Liberator P, Dulski P, Leavitt PS, Crumley T, Misura A, Murphy T, Rattray S, Samaras S, Tamas T, Mathew J, Brown C, Thompson D, Schmatz D, Fisher M, Wyvratt M..  (2005)  Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents.,  15  (13): [PMID:15922595] [10.1016/j.bmcl.2005.04.060]

Source